Estrogens, Conjugated (USP)
Showing 1 - 25 of 504
Risk Reduction, Breast Cancer Trial in United States (Bazedoxifene and Conjugated Estrogens)
Recruiting
- Risk Reduction
- Breast Cancer
- Bazedoxifene and Conjugated Estrogens
-
Duarte, California
- +4 more
Feb 14, 2022
Increased Risk for Development of Breast Cancer Trial in Kansas City (bazedoxifene plus conjugated estrogens)
Recruiting
- Increased Risk for Development of Breast Cancer
- bazedoxifene plus conjugated estrogens
-
Kansas City, KansasUniversity of Kansas Medical Center
Jan 9, 2022
Menopause, Prediabetes, Obesity Trial in New Orleans (Placebo, conjugated estrogens/bazedoxifene (CE/BZA))
Not yet recruiting
- Menopause
- +2 more
- Placebo
- conjugated estrogens/bazedoxifene (CE/BZA)
-
New Orleans, LouisianaSoutheast Louisiana Veterans Health Care System, New Orleans, LA
Jul 19, 2022
Genitourinary Syndrome of Menopause, Postmenopausal Disorder, Menopause Trial in Mexico City (3 g Polynucleotide vaginal
Recruiting
- Genitourinary Syndrome of Menopause
- +3 more
- 3 g Polynucleotide vaginal suppositories
- Conjugated estrogens cream 1g Tube
-
Mexico City, MexicoPeri-postmenopause and bone metabolism clinic. Regional Hospital
Jul 18, 2022
Atrophic Vaginitis, Menopause Trial in United States (CO2 fractionated vaginal laser, Estrogens, Conjugated (USP))
Completed
- Atrophic Vaginitis
- Menopause
- CO2 fractionated vaginal laser
- Estrogens, Conjugated (USP)
-
Stanford, California
- +5 more
Oct 16, 2019
Focus of Study is Healthy Women at Risk for Breast Cancer Trial in Kansas City (DUAVEE 0.45Mg-20Mg Tablet)
Terminated
- Focus of Study is Healthy Women at Risk for Breast Cancer
- DUAVEE 0.45Mg-20Mg Tablet
-
Kansas City, KansasUniversity of Kansas Medical Center
Oct 22, 2021
Atrophic Vaginitis, Postmenopausal Atrophic Vaginitis Trial in Fayoum (Conjugated Estrogens vaginal cream 0,625mg, platelet rich
Recruiting
- Atrophic Vaginitis
- Postmenopausal Atrophic Vaginitis
- Conjugated Estrogens vaginal cream 0,625mg
- platelet rich plasma
-
Fayoum, Fayoum University Zone, Egypt
- +1 more
Nov 22, 2021
Pelvic Organ Prolapse, Urogenital Prolapse, Vaginal Vault Prolapse Trial in Birmingham, Providence, Dallas (Conjugated Estrogens
Active, not recruiting
- Pelvic Organ Prolapse
- +6 more
- Conjugated Estrogens Cream
- Placebo Cream
-
Birmingham, Alabama
- +2 more
Nov 29, 2021
Ductal Breast Carcinoma In Situ, Postmenopausal Trial in United States (drug, other, procedure)
Recruiting
- Ductal Breast Carcinoma In Situ
- Postmenopausal
- Conjugated Estrogens/Bazedoxifene
- +5 more
-
Aurora, Colorado
- +9 more
May 27, 2021
Menopause, Depression, Anxiety, Sleep Trial (Duavive 0.45Mg-20Mg Tablet)
Not yet recruiting
- Menopause
- +2 more
- Duavive 0.45Mg-20Mg Tablet
- (no location specified)
Oct 21, 2020
Urinary Tract Infections Trial in Phoenix (Mona Lisa Touch, Conjugated estrogen, Estradiol)
Recruiting
- Urinary Tract Infections
- Mona Lisa Touch
- +2 more
-
Phoenix, ArizonaMayo Clinic in Arizona
Jan 26, 2022
Vaginitis Atropic, Pelvic Organ Prolapse, Endometrial Hyperplasia Trial (Conjugated Estrogen, Promestriene, Estriol)
Completed
- Vaginitis Atropic
- +2 more
- Conjugated Estrogen
- +3 more
- (no location specified)
Apr 29, 2019
Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in
Active, not recruiting
- Metastatic Malignant Neoplasm in Lymph Node
- +3 more
- Antiandrogen Therapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 3, 2022
Ischemia Reperfusion Injury Trial in Philadelphia (Conjugated Estrogen, Normal saline)
Recruiting
- Ischemia Reperfusion Injury
- Conjugated Estrogen
- Normal saline
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 30, 2021
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia
Recruiting
- Prostate Adenocarcinoma
- +2 more
- MRI-guided Intensity-Modulated Radiation Therapy
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023
Atrophic Vaginitis, Menopause, Recurrent Urinary Tract Infections Trial in Louisville (Conjugated equine estrogen topical cream,
Completed
- Atrophic Vaginitis
- +2 more
- Conjugated equine estrogen topical cream
- Apricot kernel oil
-
Louisville, KentuckyHealth Care Outpatient Center and Springs Medical Center
May 13, 2021
Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)
Recruiting
- Stage IV Prostate Adenocarcinoma AJCC v7
- Antiandrogen Therapy
- +5 more
-
Duarte, California
- +13 more
Feb 24, 2022
PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7
Active, not recruiting
- PSA Level Greater Than 0.03
- +4 more
- Antiandrogen Therapy
- +2 more
-
Los Angeles, California
- +1 more
Oct 14, 2021
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,
Recruiting
- Prostate Carcinoma
- +6 more
- Abiraterone Acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery
Recruiting
- Prostate Cancer
- +6 more
- Radiotherapy (SBRT) and/or surgery (metastasectomy)
- +2 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Jun 7, 2022
Overactive Bladder Trial in Maywood (conjugated estrogen)
Completed
- Overactive Bladder
- conjugated estrogen
-
Maywood, IllinoisLoyola University Medical Center
Mar 22, 2021
Menopause Trial in Baton Rouge (TSEC (Tissue-selective estrogen complexes), Placebo)
Completed
- Menopause
- TSEC (Tissue-selective estrogen complexes)
- Placebo
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jan 19, 2022
Obesity, Glucose Homeostasis, Postmenopausal Symptoms Trial in New Orleans (Bazedoxifene/Conjugated Estrogens (BZA/CE), Placebo
Completed
- Obesity
- +2 more
- Bazedoxifene/Conjugated Estrogens (BZA/CE)
- Placebo Oral Tablet
-
New Orleans, LouisianaTulane University Clinical Translational Unit
Jul 4, 2018
Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Detroit, Petoskey
Completed
- Stage I Prostate Adenocarcinoma
- +2 more
- Antiandrogen Therapy
- +3 more
-
Detroit, Michigan
- +2 more
Oct 4, 2020